|
MUTED expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.39139999997007E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.969830E-02 |
| Normal-vs-Stage2 |
1.091390E-01 |
| Normal-vs-Stage3 |
7.80230002828119E-09 |
| Normal-vs-Stage4 |
1.62847999999327E-05 |
| Stage1-vs-Stage2 |
6.227400E-01 |
| Stage1-vs-Stage3 |
4.20050000000671E-05 |
| Stage1-vs-Stage4 |
1.658410E-03 |
| Stage2-vs-Stage3 |
9.415700E-02 |
| Stage2-vs-Stage4 |
1.645570E-01 |
| Stage3-vs-Stage4 |
7.877600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.66640000000196E-05 |
| Normal-vs-AfricanAmerican |
3.41299999995215E-06 |
| Normal-vs-Asian |
8.015800E-01 |
| Caucasian-vs-AfricanAmerican |
3.823800E-02 |
| Caucasian-vs-Asian |
5.258600E-01 |
| AfricanAmerican-vs-Asian |
3.849000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.10939999997672E-06 |
| Normal-vs-Female |
4.862400E-03 |
| Male-vs-Female |
5.839600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.283600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.983700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.70939999999398E-06 |
| Normal-vs-Age(81-100Yrs) |
1.256640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.156190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.036200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.666600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.072760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.408800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.583600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.738800E-01 |
| Normal-vs-Grade 2 |
3.070000E-02 |
| Normal-vs-Grade 3 |
1.773640E-04 |
| Normal-vs-Grade 4 |
2.42570408204301E-11 |
| Grade 1-vs-Grade 2 |
5.016000E-01 |
| Grade 1-vs-Grade 3 |
1.937590E-01 |
| Grade 1-vs-Grade 4 |
8.180000E-04 |
| Grade 2-vs-Grade 3 |
8.301800E-02 |
| Grade 2-vs-Grade 4 |
1.32030000044026E-07 |
| Grade 3-vs-Grade 4 |
8.25429999999905E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.092200E-01 |
| Normal-vs-ccB subtype |
3.81383813419234E-12 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.357700E-04 |
| Normal-vs-N1 |
4.36080000000283E-05 |
| N0-vs-N1 |
1.104800E-01 |
|
|
